Johnson & Johnson Operating Income

As of the most recent data (June 2026), JNJ shows a operating income of $26B. That compares with $18B in the prior-year period — up 42.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JNJ's operating income is now $26B (was $18B) — a 42.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Johnson & Johnson is outperforming or lagging.

Tracking JNJ's operating income over time shows whether Johnson & Johnson is scaling, shrinking, or reshaping that part of the business. The current reading is $26B That compares with $18B in the prior-year period — up 42.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Johnson & Johnson's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $26B) with ownership activity and broader fundamentals.

Johnson & Johnson's operating income is $26B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.